Willows of Greensburg: Dementia Drug Missed 3 Weeks - IN
The incident at Willows of Greensburg involved a severely cognitively impaired resident with non-Alzheimer's dementia, atrial fibrillation, and hypertension. Federal inspectors reviewed the case during a complaint investigation in August.
On June 22, a physician ordered the resident to receive Memantine, a cognition medication, at 5 milligrams twice daily. The drug is specifically designed to help manage symptoms of moderate to severe dementia.
But on July 7, a nurse discontinued the medication order with a note stating "Meds from home no interchange needed." The resident's medication administration record showed no Memantine doses were given from July 8 through July 28.
Nobody noticed.
The resident went 21 days without the prescribed cognition medication while staff remained unaware of the error. During this period, the severely cognitively impaired patient received no treatment specifically targeting their dementia symptoms.
Family members discovered the missing medication on July 28 and contacted the facility. A health status note from August 8 documented that "the family notified the facility of discontinuance of memantine on 7/07/2025."
When inspectors interviewed RN 2 on August 14, the nurse admitted responsibility for the mistake. She told investigators that "on 7/07/25 she discontinued Resident B's Memantine medication on accident, and the family notified her of the missing medication on 7/28/2025."
The medication was restarted the day after the family's call. On July 29, a new physician's order prescribed Memantine extended release at 14 milligrams daily, a different formulation and dosage than the original prescription.
The three-week gap represented a significant interruption in dementia care for a patient whose cognitive impairment was already severe. Memantine works by regulating brain activity that becomes disrupted in dementia patients, and consistent dosing is considered important for maintaining whatever cognitive function remains.
The facility's own medication policy, dated July 2023, requires staff to "ensure medications/treatments are provided to residents in accordance with the order." The Director of Nursing provided this policy to inspectors during their review.
Federal inspectors classified the violation as causing minimal harm or potential for actual harm to few residents. The case emerged from a complaint filed with state health officials, designated as Complaint 2587102.
The inspection report does not indicate whether the facility conducted any internal review of how the medication error occurred or what steps were taken to prevent similar incidents. It also does not document whether other residents' medications were reviewed for similar discontinuation errors.
The accidental discontinuation highlights the vulnerability of cognitively impaired residents who cannot advocate for themselves when medications go missing. In this case, family members served as the safety net that facility systems failed to provide.
For dementia patients, medication continuity can be especially critical as their condition progresses. The resident's severe cognitive impairment would have made it impossible for them to notice or report the missing medication, leaving them entirely dependent on staff accuracy and family oversight.
The error also raises questions about the facility's medication reconciliation processes. Standard protocols typically require multiple checks when medications are discontinued, particularly for residents with serious cognitive conditions who rely on family involvement in their care.
The resident ultimately received their cognition medication again, but only after family members discovered the three-week gap. The facility's medication administration records documented the entire period without doses, creating a clear timeline of the oversight that went undetected by nursing staff.
Federal regulations require nursing homes to provide pharmaceutical services that meet each resident's needs and to employ or obtain services from licensed pharmacists. The Willows of Greensburg violation suggests gaps in the systems designed to ensure consistent medication delivery for vulnerable residents.
The case was resolved when the medication was restarted, but the inspection report provides no indication of broader systemic changes to prevent similar medication errors from affecting other residents at the facility.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Willows of Greensburg from 2025-08-14 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 21, 2026 · Our methodology
WILLOWS OF GREENSBURG in GREENSBURG, IN was cited for violations during a health inspection on August 14, 2025.
The incident at Willows of Greensburg involved a severely cognitively impaired resident with non-Alzheimer's dementia, atrial fibrillation, and hypertension.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.